AxoGen Inc

NASDAQ:AXGNUnited States

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.

Contact Information

Headquarters

SUITE 100, 13859 PROGRESS BLVD.ALACHUA, FL, United States 32615

Phone

386-462-6817

Fax

386-462-6801

Executives

Independent Chairman of the Board

Paul Thomas

President, Chief Executive Officer, Director

Michael Dale

Chief Financial Officer

Nir Naor

Executive Vice President, General Counsel

Marc Began

Chief Marketing Officer

Jens Kemp